How to Save Money on Dasatinib in 2026: Coupons, Discounts, and Patient Assistance

Dasatinib (brand name Sprycel) is one of the most expensive oral cancer medications on the market. The retail price for a 30-day supply of brand Sprycel 100 mg can exceed $27,000—and even the generic version lists at over $22,000 without any discounts. These numbers are alarming, but they don't reflect what most patients actually pay. With the right combination of insurance, copay programs, and discount coupons, most patients can dramatically reduce their out-of-pocket cost.

Here's a complete breakdown of every savings option available for dasatinib in 2026.

What Does Dasatinib Actually Cost in 2026?

Here are the real-world price ranges you may encounter:

• Brand Sprycel (100 mg, 30 tablets) retail: ~$17,800–$27,800 per month depending on pharmacy
• Generic dasatinib (100 mg, 30 tablets) retail: ~$20,000–$22,000 per month
• Generic dasatinib with GoodRx coupon: As low as ~$824 per 30-day supply
• Generic dasatinib with SingleCare coupon: As low as ~$891 per 30-day supply
• With commercial insurance: Specialty tier copay, typically $50–$500+ depending on plan; copay cards can reduce this to $0
• With Medicare Part D: Annual out-of-pocket cap of $2,100 in 2026 (after which Part D pays 100% for the remainder of the year)

Option 1: Use GoodRx or SingleCare Coupons for Generic Dasatinib

If you don't have insurance, or if your insurance copay is higher than the cash price with a coupon, using a GoodRx or SingleCare coupon for generic dasatinib may be your best option. These coupons can bring the price down from $22,000 to approximately $824–$891 per 30-day supply—a reduction of over 96%.

Important caveat: you cannot use a discount coupon and your insurance at the same time. If your insurance copay is less than the coupon price, use your insurance. If your insurance copay is more, the coupon may be cheaper. You can also use a coupon as a bridge while waiting for insurance approval.

Note: Not all pharmacies that accept GoodRx stock dasatinib. You'll need to call ahead to confirm availability at your chosen pharmacy.

Option 2: Apotex Dasatinib Instant Savings Card (Commercially Insured)

If you have commercial insurance and are taking generic dasatinib manufactured by Apotex, the Dasatinib Instant Savings Program can reduce your out-of-pocket cost to $0. The program pays up to $625 per 30-day supply not covered by your primary insurance, up to a maximum of $7,500 per calendar year.

Eligibility: You must have commercial insurance (not Medicare, Medicaid, TRICARE, or other government programs). You must not be uninsured. Call (833) 415-4368 to enroll or visit dasatinibcopay.com.

Option 3: BMS Access Support for Sprycel (Commercially Insured)

Bristol-Myers Squibb offers the BMS Access Support program for commercially insured patients prescribed brand Sprycel. This program provides copay assistance and helps coordinate prior authorization and specialty pharmacy enrollment. Contact your oncologist's office or visit sprycel.com/financial-support to enroll.

Option 4: BMS Patient Assistance Foundation (Uninsured/Underinsured)

If you don't have prescription drug insurance and can't afford dasatinib, the BMS Patient Assistance Foundation may provide Sprycel at no charge. Eligibility is based on income and insurance status. Your oncologist can help with the application process, or you can find information through the Partnership for Prescription Assistance (PPA).

Option 5: Medicare Part D — The $2,100 Out-of-Pocket Cap in 2026

As of 2026, Medicare Part D has a $2,100 annual out-of-pocket cap. This is a significant benefit for seniors taking specialty drugs like dasatinib. Once you've spent $2,100 out-of-pocket in a calendar year on Part D drugs, your plan covers 100% of your covered prescriptions for the rest of the year. For context, dasatinib could hit this cap very quickly given its specialty tier cost-sharing.

Option 6: Leukemia and Lymphoma Society Co-Pay Assistance

The Leukemia and Lymphoma Society (LLS) offers co-pay financial assistance specifically for blood cancer patients, including those with CML and ALL. LLS grants can help cover your insurance copays, premiums, and other treatment-related expenses. Visit lls.org/financial-support to apply.

Option 7: 340B Program (for Qualifying Patients at Covered Entities)

If you receive treatment at a 340B-covered entity (including many federally qualified health centers, cancer hospitals, and academic medical centers), you may be eligible for substantially reduced drug prices through the 340B Drug Pricing Program. Ask your treatment center if they participate in 340B.

Which Savings Option Is Best for You?

The best option depends on your insurance status. Talk to your oncologist's billing office or a financial counselor at your cancer center to identify the right combination of programs. If you also need help locating a pharmacy that has your medication in stock, use medfinder or read our guide on how to find dasatinib near you.